Anal canal cancer clinical practice guidelines in oncology

Paul F. Engstrom*, Al B. Benson, Yi Jen Chen, Michael A. Choti, Raza A. Dilawari, Charles A. Enke, Marwan G. Fakih, Charles Fuchs, Krystyna Kiel, James A. Knol, Lucille A. Leong, Kirk A. Ludwig, Edward W. Martin, Sujata Rao, M. Wasif Saif, Leonard Saltz, John M. Skibber, Alan P. Venook, Timothy J. Yeatman

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

An estimated 3,990 new cases of anal cancer will occur in 2005, accounting for approximately 1.6% of digestive system cancers in the United States. Prognosis directly depends on the size of the primary tumor and the likelihood of lymphatic spread, with tumors 2 cm or smaller cured in 80% of cases. The NCCN guidelines recommend a thorough evaluation for any patient with a suspicious lesion in the anal canal and include additional recommendations for diagnosis, treatment, and follow up for anal canal cancer.

Original languageEnglish (US)
Pages (from-to)510-515
Number of pages6
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume3
Issue number4
StatePublished - Jul 1 2005

Keywords

  • Anal neoplasms
  • Biopsy
  • NCCN clinical practice guidelines
  • Neoplasm staging
  • Surgery

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Anal canal cancer clinical practice guidelines in oncology'. Together they form a unique fingerprint.

Cite this